(2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone
97%
- Product Code: 166598
CAS:
2169998-23-4
| Molecular Weight: | 422.86 g./mol | Molecular Formula: | C₂₁H₂₃ClO₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in the synthesis of SGLT2 inhibitors for the treatment of type 2 diabetes. It serves as a key intermediate in developing antidiabetic drugs that enhance glucose excretion through the kidneys by blocking glucose reabsorption. Its structure supports high selectivity and potency in inhibiting the SGLT2 protein, contributing to improved glycemic control. Commonly employed in pharmaceutical research and development for oral hypoglycemic agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | ฿348,960.00 |
+
-
|
(2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone
Used in the synthesis of SGLT2 inhibitors for the treatment of type 2 diabetes. It serves as a key intermediate in developing antidiabetic drugs that enhance glucose excretion through the kidneys by blocking glucose reabsorption. Its structure supports high selectivity and potency in inhibiting the SGLT2 protein, contributing to improved glycemic control. Commonly employed in pharmaceutical research and development for oral hypoglycemic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :